Sanara Medtech Stock Alpha and Beta Analysis
| SMTI Stock | USD 37.70 0.38 1.02% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Sanara Medtech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Sanara Medtech over a specified time horizon. Remember, high Sanara Medtech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Sanara Medtech's market risk premium analysis include:
Beta (0.15) | Alpha 0.26 | Risk 3.22 | Sharpe Ratio 0.0645 | Expected Return 0.21 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Sanara |
Sanara Medtech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Sanara Medtech market risk premium is the additional return an investor will receive from holding Sanara Medtech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sanara Medtech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Sanara Medtech's performance over market.| α | 0.26 | β | -0.15 |
Sanara Medtech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Sanara Medtech's Buy-and-hold return. Our buy-and-hold chart shows how Sanara Medtech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Sanara Medtech Market Price Analysis
Market price analysis indicators help investors to evaluate how Sanara Medtech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sanara Medtech shares will generate the highest return on investment. By understating and applying Sanara Medtech stock market price indicators, traders can identify Sanara Medtech position entry and exit signals to maximize returns.
Sanara Medtech Return and Market Media
The median price of Sanara Medtech for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 33.4 with a coefficient of variation of 6.72. The daily time series for the period is distributed with a sample standard deviation of 2.22, arithmetic mean of 33.12, and mean deviation of 1.78. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Sanara MedTech Inc Shares Gap Down to 32.815 on Sep 16 | 09/16/2024 |
2 | Sanara MedTechs investors will be pleased with their solid 259 percent return over the last five years | 09/24/2024 |
3 | Acquisition by Ortwein Sara N of 3440 shares of Sanara Medtech subject to Rule 16b-3 | 10/03/2024 |
4 | Insider Trading | 10/04/2024 |
5 | Sanara MedTech Inc Shares Down 3.18 percent on Oct 7 | 10/07/2024 |
6 | Sanara MedTech Inc Stock Price Up 4.87 percent on Oct 18 | 10/18/2024 |
7 | Sanara MedTech Inc. insiders have significant skin in the game with 30 percent ownership | 11/04/2024 |
8 | Acquisition by Morrison Christopher A. of 7135 shares of Sanara Medtech subject to Rule 16b-3 | 11/07/2024 |
9 | Acquisition by Myers Keith G of 1975 shares of Sanara Medtech subject to Rule 16b-3 | 11/11/2024 |
10 | Sanara MedTech Inc Q3 2024 Earnings Call Highlights Record Revenue Growth and Strategic ... | 11/14/2024 |
11 | Sanara MedTech Inc. Just Reported Earnings, And Analysts Cut Their Target Price | 11/15/2024 |
About Sanara Medtech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Sanara or other stocks. Alpha measures the amount that position in Sanara Medtech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.0308 | 0.0324 | Price To Sales Ratio | 5.24 | 4.97 |
Sanara Medtech Upcoming Company Events
As portrayed in its financial statements, the presentation of Sanara Medtech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sanara Medtech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Sanara Medtech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Sanara Medtech. Please utilize our Beneish M Score to check the likelihood of Sanara Medtech's management manipulating its earnings.
| 18th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 18th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Sanara Medtech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Sanara Medtech Backtesting, Sanara Medtech Valuation, Sanara Medtech Correlation, Sanara Medtech Hype Analysis, Sanara Medtech Volatility, Sanara Medtech History and analyze Sanara Medtech Performance. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Sanara Medtech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.